Emsam

NDA 21708, held by Somerset. Selegiline.

As of Nov 14, 2026, NDA 21708 (Emsam), held by Somerset, was first approved by FDA on Feb 27, 2006, with 0 approved supplements and 0 published complete response letters.

• First approved: Feb 27, 2006
• Review: Standard
• Supplements approved: 0
• Complete response letters: 0

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters